Audited Financial Results for the quarter and year ended 31.03.2026.
TRANSPEK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 11.0 pts less than Nifty Microcap 250 and 11.1 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Transpek Industry Limited has released its audited standalone and consolidated financial results for FY2026 (year ended March 31, 2026). The Board of Directors declared a dividend of Rs.20 per share (200% on face value of Rs.10). Auditors Bansi S. Mehta & Co. issued an unmodified (clean) opinion on both standalone and consolidated financial statements. The company has one wholly-owned subsidiary, Transpek Creative Chemistry Private Limited. The audit report confirms no material uncertainty regarding going concern. The AGM is scheduled for September 15, 2026. Specific revenue, profit, or margin figures are not detailed in this filing as they would be in the attached financial statements.
A clean audit opinion and 200% dividend declaration indicate a financially healthy company. No red flags for investors. The clean audit removes concerns about financial reporting quality.